Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study.
Growth Horm IGF Res
; 67: 101500, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36113378
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Human Growth Hormone
/
Dwarfism, Pituitary
Type of study:
Clinical_trials
/
Guideline
Aspects:
Ethics
Limits:
Humans
/
Male
Language:
En
Journal:
Growth Horm IGF Res
Journal subject:
ENDOCRINOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Japón